Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium for Post-Cardiac Arrest Care
NCT02260258Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rocuronium in cardiac arrest (SCA), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2014; status: completed.
02
Drugs
rocuronium
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02260258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260258.